432 related articles for article (PubMed ID: 11935154)
1. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
2. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
5. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O
J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
[TBL] [Abstract][Full Text] [Related]
7. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
Suarez-Pinzon WL; Rabinovitch A
Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Shapiro AM; Rajotte RV; Power R
Diabetes; 2002 Mar; 51(3):638-45. PubMed ID: 11872661
[TBL] [Abstract][Full Text] [Related]
11. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
[TBL] [Abstract][Full Text] [Related]
13. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
15. MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
Panerai AE; Nicoletti F; Sacedote P; Arvidsson L; Conget I; Gomis R; Bartorelli A; Sandler S
Diabetologia; 2001 Jul; 44(7):839-47. PubMed ID: 11508268
[TBL] [Abstract][Full Text] [Related]
16. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
17. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
18. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
[TBL] [Abstract][Full Text] [Related]
20. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
Saldeen J; Sandler S; Bendtzen K; Welsh N
Cytokine; 2000 Apr; 12(4):405-8. PubMed ID: 10805224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
